May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Retinal Transplantation of Neural Precursor Cells and Their Gene-Modification
Author Affiliations & Notes
  • Y. Mawatari
    Ophthalmology, Kumamoto Univ Sch Med, Kumamoto, Japan
  • M. Fukushima
    Ophthalmology, Kumamoto Univ Sch Med, Kumamoto, Japan
  • T. Inoue
    Ophthalmology, Kumamoto Univ Sch Med, Kumamoto, Japan
  • T. Setoguchi
    Cell Fate Modulation, Institute of Molecular Embryology and Genetics, Kumamoto Univ Sch Med, Kumamoto, Japan
  • T. Taga
    Cell Fate Modulation, Institute of Molecular Embryology and Genetics, Kumamoto Univ Sch Med, Kumamoto, Japan
  • H. Tanihara
    Cell Fate Modulation, Institute of Molecular Embryology and Genetics, Kumamoto Univ Sch Med, Kumamoto, Japan
  • Footnotes
    Commercial Relationships  Y. Mawatari, None; M. Fukushima, None; T. Inoue, None; T. Setoguchi, None; T. Taga, None; H. Tanihara, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 1680. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Y. Mawatari, M. Fukushima, T. Inoue, T. Setoguchi, T. Taga, H. Tanihara; Retinal Transplantation of Neural Precursor Cells and Their Gene-Modification . Invest. Ophthalmol. Vis. Sci. 2003;44(13):1680.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: In mammals, matured retina does not show regenerative capacity after injury. Development of renewable cell source is required for retinal transplantation therapy. This study was conducted in an attempt to investigate possibility of gene-modified neural precursor cells (NPCs), as a potential cell source is required for retinal transplantation. Methods: NMDA (4mM, 5ul) was injected into the intravitreal space of adult rat to induce retinal cell death. NPCs were prepared from the telencephalic neuroepithelium of EGFP (enhanced green fluorescence protein) transgenic mice on embryonic day 14. Cell suspension (5x105 cells) was injected into intravitreal or subretinal space of NMDA-treated eyes. At 1, 2 or 4 wk after transplantation, sections were prepared for immunohistochemistry. Overexpression of neurogenin (ngn) 2, a basic helix-loop-helix transcriptional factor, in NPCs was performed with a retrovirus vector encoding ngn2-IRES-EGFP. Results: NPCs prepared from EGFP transgenic mice have a potential to differentiate into GFAP-positive (glial) and bÖ°-tubulin-positive (neuronal) cells. Retinal transplantation of NPCs revealed that the transplanted cells survive for at least 28 days and differentiate into both glial and neuronal cells with a preference of the former. Markers for retinal cell types were not expressed in the transplanted cells. Retrovirus-mediated gene expression of ngn 2 in NPCs led to appearance of more neuronal cells in vitro. Our in vivo experiments showed the possibility and usefulness of retinal transplantation of gene-modified NPCs as a novel cell source for retinal regenerative therapy. Conclusions: We demonstrated that the transplanted NPCs are viable in the matured retina for at least 28 days. We also showed neurogenic differentiation of NPCs by ngn 2 expression.

Keywords: transplantation • cell adhesions/cell junctions • retinal connections, networks, circuitry 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×